Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

High-frequency repetitive transcranial magnetic stimulation helps treating depression in stroke survivors

Posted by on Jun 14, 2019 in Stroke | 0 comments

In a nutshell This study investigated the effectiveness and safety of high-frequency repetitive transcranial magnetic stimulation (HF-RTMS) to treat depression in patients with stroke. Researchers suggested that HF-RTMS improved depression in these patients. Some background A stroke occurs when blood flow to an area of the brain is cut off. When this...

Read More

Nerve grafting to restore erectile function after radical prostatectomy

Posted by on Jun 7, 2019 in Erectile dysfunction | 0 comments

In a nutshell This article investigated the safety and efficacy of end-to-side nerve grafting surgery (NGS) in patients with erectile dysfunction (ED) after prostate surgery. The authors concluded that NGS was a safe and effective treatment option for these patients. Some background Radical prostatectomy (RP) is surgery to remove the prostate. It...

Read More

What factors can influence the effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder?

Posted by on Jun 6, 2019 in Overactive bladder | 0 comments

In a nutshell This article investigated the factors that can predict treatment success of percutaneous tibial nerve stimulation (PTNS) for overactive bladder (OAB). The authors concluded that a history of depression/anxiety and severe urgency urinary incontinence (UUI; needing to urinate urgently) before treatment predicted a higher chance of...

Read More

Evaluating the long-term outcomes of low-dose radiation therapy for early-stage nodular lymphocyte-predominant Hodgkin lymphoma

Posted by on Jun 5, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness of radiation, chemotherapy, or both for the treatment of early-stage nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL). This study concluded that long-term outcomes were favorable across all treatment approaches. Some background NLPHL is a rare subtype of non-Hodgkin's lymphoma....

Read More

Evaluating quality of life after pembrolizumab treatment for classical Hodgkin lymphoma

Posted by on Jun 5, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This phase 2 study evaluated the impact of pembrolizumab (Keytruda) on the quality of life of patients with classical Hodgkin’s lymphoma (cHL) that has come back or stopped responding to treatment. This study concluded that the overall quality of life and health status was improved for these patients. Some background Most patients...

Read More

Evaluating polatuzumab vedotin with chemoimmunotherapy for diffuse large B-cell lymphoma

Posted by on Jun 5, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness and safety of polatuzumab vedotin (Pola) combined with chemoimmunotherapy for patients with diffuse large B-cell lymphoma (DLBCL). This study concluded that combining Pola with these regimens was promising, with manageable side effects. Some background DLBCL is one of the most common types...

Read More